Effect of Nintedanib on Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis (IPF): Results from a Phase IIIb Trial

被引：0
|
作者：
Lancaster, L. H. [1 ]
Conoscenti, C. S. [2 ]
Ilowite, J. [3 ]
Trampisch, M. [4 ]
Mogulkoc, N. [5 ]
Homik, L. [6 ]
Kaye, M. [7 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[3] NYU Winthrop, Div Pulm & Crit Care, Mineola, NY USA
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[5] Ege Univ, Sch Med, Izmir, Turkey
[6] Winnipeg Clin, Winnipeg, MB, Canada
[7] Minnesota Lung Ctr Ltd, Minneapolis, MN USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4266
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis (IPF): the INSTAGE trial
    Kolb, Martin
    Wells, Athol
    Behr, Juergen
    Richeldi, Luca
    Schinzel, Birgit
    Quaresma, Manuel
    Stowasser, Susanne
    Raghu, Ganesh
    Martinez, Fernando J.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [2] Improvement In Forced Vital Capacity (FVC) With Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): Results From The Inpulsis Trials
    Flaherty, K. R.
    Kolb, M.
    Vancheri, C.
    Tang, W.
    Conoscenti, C. S.
    Richeldi, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [3] Effect Of Nintedanib On Disease Progression In The Inpulsis® Trials In Patients With Idiopathic Pulmonary Fibrosis (ipf)
    Raghu, G.
    Inoue, Y.
    Behr, J.
    Cottin, V.
    Stowasser, S.
    Stansen, W.
    Maher, T. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [4] Predicting Mortality in Idiopathic Pulmonary Fibrosis (IPF) Patients Treated with Nintedanib
    Tang, W.
    Menjoge, S.
    Stowasser, S.
    Korell, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [5] Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
    Kawada, Tomoyuki
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (09) : 1274 - +
  • [6] High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib Methodology of the HOPE-IPF Study
    Ryerson, Christopher J.
    Camp, Pat G.
    Eves, Neil D.
    Schaeffer, Michele
    Syed, Nafeez
    Dhillon, Satvir
    Jensen, Dennis
    Maltais, Francois
    O'Donnell, Denis E.
    Raghavan, Natya
    Roman, Michael
    Stickland, Michael K.
    Assayag, Deborah
    Bourbeau, Jean
    Dion, Genevieve
    Fell, Charlene D.
    Hambly, Nathan
    Johannson, Kerri A.
    Kalluri, Meena
    Khalil, Nasreen
    Kolb, Martin
    Manganas, Helene
    Moran-Mendoza, Onofre
    Provencher, Steve
    Ramesh, Warren
    Rolf, J. Douglass
    Wilcox, Pearce G.
    Guenette, Jordan A.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (09) : 1640 - 1647
  • [7] Changes in biomarkers in patients with idiopathic pulmonary fibrosis (IPF) treated with nintedanib and sildenafil
    White, Eric
    Crestani, Bruno
    Guenther, Andreas
    Maher, Toby M.
    Ittrich, Carina
    Diefenbach, Claudia
    Rohr, Klaus B.
    Quaresma, Manuel
    Kolb, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [8] Gene Expression Profiling in Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Nintedanib and Sildenafil: Data from the INSTAGE Trial
    Bonella, F.
    Kolb, M.
    White, E. S.
    Cottin, V.
    de Andrade, J.
    Glaspole, I.
    Strobel, B.
    Roy, J.
    Ittrich, C.
    Diefenbach, C.
    Rohr, K. B.
    Quaresma, M.
    Martinez, F. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [9] Safety of Combined Pirfenidone and Nintedanib in Subgroups of Patients with Idiopathic Pulmonary Fibrosis (IPF)
    Flaherty, K.
    Fell, C. D.
    Huggins, J. T.
    Nunes, H.
    Sussman, R.
    Valenzuela, C.
    Petzinger, U.
    Stauffer, J. L.
    Gilberg, F.
    Bengus, M.
    Wijsenbeek, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [10] Colitis Associated with Nintedanib Therapy for Idiopathic Pulmonary Fibrosis (IPF)
    Oda, Keishi
    Matsunaga, Takafumi
    Sennari, Konomi
    Yatera, Kazuhiro
    INTERNAL MEDICINE, 2017, 56 (10) : 1267 - 1268
12345